Hisamitsu Pharmaceutical Co., Inc. (TYO: 4530)
Japan
· Delayed Price · Currency is JPY 4,543.00
-52.00 (-1.13%)
Jan 20, 2025, 3:30 PM JST
Hisamitsu Pharmaceutical Co. Revenue
Hisamitsu Pharmaceutical Co. had revenue of 35.80B JPY in the quarter ending November 30, 2024, a decrease of -0.15%. This brings the company's revenue in the last twelve months to 150.13B, up 7.79% year-over-year. In the fiscal year ending February 29, 2024, Hisamitsu Pharmaceutical Co. had annual revenue of 141.71B with 10.42% growth.
Revenue (ttm)
150.13B
Revenue Growth
+7.79%
P/S Ratio
2.25
Revenue / Employee
54.42M
Employees
2,759
Market Cap
331.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 29, 2024 | 141.71B | 13.38B | 10.42% |
| Feb 28, 2023 | 128.33B | 8.14B | 6.77% |
| Feb 28, 2022 | 120.19B | 5.68B | 4.96% |
| Feb 28, 2021 | 114.51B | -26.48B | -18.78% |
| Feb 29, 2020 | 140.99B | -2.42B | -1.68% |
| Feb 28, 2019 | Pro | Pro | Pro |
| Feb 28, 2018 | Pro | Pro | Pro |
| Feb 28, 2017 | Pro | Pro | Pro |
| Feb 29, 2016 | Pro | Pro | Pro |
| Feb 28, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,142.35B |
| Daiichi Sankyo Company | 1,758.07B |
| HOYA Corporation | 812.74B |
| Takeda Pharmaceutical Company | 4,546.08B |
| Otsuka Holdings | 2,269.56B |
| Terumo | 986.67B |
| Astellas Pharma | 1,772.16B |
| Olympus | 973.60B |